Balance Sheet
Accumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ayr Wellness (AYWWF) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Ayr Wellness (AYWWF) over the last 7 years, with Q1 2025 value amounting to $37.6 million.

  • Ayr Wellness' Cash & Equivalents fell 4713.69% to $37.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was $37.6 million, marking a year-over-year decrease of 4713.69%. This contributed to the annual value of $35.5 million for FY2024, which is 3010.68% down from last year.
  • Latest data reveals that Ayr Wellness reported Cash & Equivalents of $37.6 million as of Q1 2025, which was down 4713.69% from $35.5 million recorded in Q4 2024.
  • In the past 5 years, Ayr Wellness' Cash & Equivalents registered a high of $195.6 million during Q1 2021, and its lowest value of $35.5 million during Q4 2024.
  • Its 5-year average for Cash & Equivalents is $88.5 million, with a median of $76.8 million in 2022.
  • In the last 5 years, Ayr Wellness' Cash & Equivalents skyrocketed by 229540.27% in 2021 and then plummeted by 6110.59% in 2023.
  • Over the past 5 years, Ayr Wellness' Cash & Equivalents (Quarter) stood at $154.3 million in 2021, then crashed by 50.22% to $76.8 million in 2022, then plummeted by 33.92% to $50.8 million in 2023, then tumbled by 30.11% to $35.5 million in 2024, then grew by 6.08% to $37.6 million in 2025.
  • Its Cash & Equivalents was $37.6 million in Q1 2025, compared to $35.5 million in Q4 2024 and $50.6 million in Q3 2024.